Artificial Intelligence | Machine Learning | Machine Perception Whitelab Genomics | AI/ML for Genomic Therapies


Enterprise, Biotherapies, Gene Therapy, RNA Therapy, Cell Therapy Paris , France

Whitelab Genomics

Artificial Intelligence | Machine Learning | Machine Perception


Whitelab Genomics | AI/ML for Genomic Therapies

Whitelab Genomics

Biotherapies, Gene Therapy, RNA Therapy, Cell Therapy


Paris , France

Our proprietary platform leverages graph knowledge technology and machine learning to help our customers discover and design new genomic therapies. Based on exhaustive datasets, the platform provides in-silico simulations to discover and design optimized payloads and vectors. Thanks to our advanced software solutions and proprietary database, scientists in the field of genomic medicine are able to obtain precise and exhaustive answers to key scientific and technological questions such as optimizing payload and vector design, assessing genotoxicity, and identifying optimal experimental protocols for in vivo and in vitro strategies.

Gene therapy is a revolutionary treatment designed to introduce a functional copy of a gene into cells in place of missing or defective ones in order to correct genetic disorders. Therapeutic effect can be achieved through insertion, deletion, inactivation, or modification of genetic sequences. RNA therapeutics are a new class of medications based on ribonucleic acid (RNA). These drugs can either trigger protein synthesis to promote a new therapeutics effect, such as a vaccine, or they can activate an interfering mechanism in order to suppress pathological protein pathway expression  and block the disease. Cell therapy is a therapy in which viable cells are injected or implanted into a patient to trigger a medicinal effect. These cells are originally collated from a patient, cultured and transformed in vitro with therapeutic genetic material. The transformed cells which have the capability to cure the symptoms are re-injected in the patient. 

 

B2B

1 to 25

Seed

$10M

Scaling Up

2019

 
 

Biotechnology

Target Discovery
Correct Genetic Disorders

Increase Efficiency

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception


Biotechnology

Biotechnology


Image

Image

Video

Video

Text

Text

Structured

Structured

 

   Software


Python

Python

C/C++

C/C++

Tensorflow

Tensorflow

Kubernetes

Kubernetes

Typescript

Typescript

JavaScript

JavaScript

Node.js

Node.js

ADAS

ADAS


Search Algorithm

Search Algorithm

Machine Learning Algorithm

Machine Learning Algorithm

Deep Learning Algorithm

Deep Learning Algorithm

 
 

Jan 2021

  • WhiteLab Genomics Partnered with ART-TG
 
 

View All

View All AI/ML Jobs

Lead Data Scientist

Paris, Paris

Computational Biologist

Paris, Paris

 

AI/ML Professionals

Want to work at Whitelab Genomics?

We can introduce you to the right person at Whitelab Genomics

Talk to our Talent Team

 

2

1

$10M

Company was founded 2019 and it took almost 3 years (Sep 2022) to raise first external round

 
 

Date

Round

$ Raised

Investors

09/13/2022

Series A

$10M

Debiopharm Innovation Fund, Omnes Capital

Date : 09/13/2022

Round: Series A

$ Raised: $10M

Investors: Debiopharm Innovation Fund, Omnes Capital

 

Investors

Interested in researching Whitelab Genomics?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Whitelab Genomics

Request a Demo - Deal Souring Platform

 
David Bourgo

David Bourgo
CEO co-founder

Julien Cottineau

Julien Cottineau
Chief Scientific Officer CSO

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Whitelab Genomics